Evidence map›Paper›PMID 25336790›Full record

ReviewIndian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology2014

Oligometastatic breast cancer: A mini review.

Sameer Rastogi, Seema Gulia, Jyoti Bajpai, Jaya Ghosh, Sudeep Gupta

Abstract readReview
In one paragraph

Review in Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Breast surgery for metastatic breast cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Article
  4. Breast cancer metastasis to thymus.BMJ case reports · 2023
    Article
  5. Article
  6. Diagnosis of oligometastasis.Translational cancer research · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sameer RastogiDepartment of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India.
Seema GuliaDepartment of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India.
Jyoti BajpaiDepartment of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India.
Jaya GhoshDepartment of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India.
Sudeep GuptaDepartment of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With few exceptions such as germ cell tumors, trophoblastic neoplasms and colonic cancers, metastatic solid tumors are considered largely incurable. It is increasingly appreciated that oligometaststic cancer differs from multi-metastatic disease in prognosis and survival. Oligometastatic breast cancer (OMBC) is, therefore, sometimes considered as an intermediate biological state between localized and widely metastatic disease. There is no strict definition of OMBC with studies using different criteria. Treatment of OMBC is still controversial in view of sparse data that is retrospective. However, there is an increasing shift toward individualized, multidisciplinary management of OMBC with the intent to cure some patients. This article will concisely review the subject of OMBC from points of view of biology and practical management recommendations.

Indexed as

breast cancercureOligometastastasis

Identifiers

PMID25336790
PMCPMC4202615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.